Zach System is committed to providing Highly Customized Solutions for all your Development Programs.
01 1ZACH SYSTEM SA
02 2Farmabios S.p.A.
03 1Aarti Pharmalabs Limited
04 1Curia Spain S.A.U.
05 2Industriale Chimica s.r.l.
06 5Isomedix Operations Inc
01 3LOTEPREDNOL ETABONATE
02 4Loteprednol Etabonate
03 5loteprednol etabonate
01 1France
02 2Germany
03 1India
04 2Italy
05 6U.S.A
Zach System is committed to providing Highly Customized Solutions for all your Development Programs.
NDC Package Code : 60269-287
Start Marketing Date : 1998-03-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Axplora- The partner of choice for complex APIs.
NDC Package Code : 46439-8743
Start Marketing Date : 2012-04-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
NDC Package Code : 15308-0722
Start Marketing Date : 2011-06-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Axplora- The partner of choice for complex APIs.
NDC Package Code : 46439-8744
Start Marketing Date : 2012-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63190-0220
Start Marketing Date : 1998-03-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55718-142
Start Marketing Date : 2004-12-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 55718-152
Start Marketing Date : 1998-03-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 55718-153
Start Marketing Date : 2011-04-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 55718-154
Start Marketing Date : 1998-09-03
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 55718-155
Start Marketing Date : 2012-10-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : DRUG FOR FURTHER PROCESSING
A Loteprednol Etabonate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Loteprednol Etabonate, including repackagers and relabelers. The FDA regulates Loteprednol Etabonate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Loteprednol Etabonate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Loteprednol Etabonate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Loteprednol Etabonate supplier is an individual or a company that provides Loteprednol Etabonate active pharmaceutical ingredient (API) or Loteprednol Etabonate finished formulations upon request. The Loteprednol Etabonate suppliers may include Loteprednol Etabonate API manufacturers, exporters, distributors and traders.
click here to find a list of Loteprednol Etabonate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Loteprednol Etabonate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Loteprednol Etabonate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Loteprednol Etabonate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Loteprednol Etabonate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Loteprednol Etabonate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Loteprednol Etabonate suppliers with NDC on PharmaCompass.
We have 6 companies offering Loteprednol Etabonate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
